Additional file 1 of Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients
Additional file 1: Suppl. Figure S1. Effects of NF-YA inactivation by RNAi in vitro and in vivo. (A) Cell proliferation curve measured by MTT assay of PC3 cells infected with scramble (shCTR) and NF-YA-targeting shRNA (shNF-YA). Data represent mean ± SEM (multiple t-test corrected by the Holm-Sidak method: *p<0.05, **p<0.01, n=4). (B) Images of xenograft tumors dissected from SCID Hairless Outbred (SHO®) mice after 5 weeks from s.c. injection of shCTR and shNF-YA cells (7 mice per group).